Naproxen

Nonsteroidal Anti-Inflammatory Drug (NSAID) for Pain, Inflammation & Fever

OTC ATC: M01AE02 NSAID
Active Ingredient
Naproxen
Available Forms
Tablet, Enteric-coated tablet, Capsule
Common Strengths
200 mg, 250 mg, 500 mg
Known Brands
Naprosyn, Aleve, Pronaxen, Naprocur

Naproxen is a widely used nonsteroidal anti-inflammatory drug (NSAID) that relieves pain, reduces inflammation, and lowers fever. Available over-the-counter in many countries, it is commonly used for headache, toothache, menstrual cramps, muscle and joint pain, back pain, and acute migraine in adults. Naproxen stands out among NSAIDs for its long duration of action, typically requiring only twice-daily dosing. As with all NSAIDs, it should be used at the lowest effective dose for the shortest possible time to minimize the risk of gastrointestinal and cardiovascular side effects.

Quick Facts

Active Ingredient
Naproxen
Drug Class
NSAID
ATC Code
M01AE02
Common Uses
Pain & Inflammation
Available Forms
Tablet, Capsule
Prescription Status
OTC / Rx

Key Takeaways

  • Naproxen is an NSAID that relieves pain, reduces inflammation, and lowers fever by inhibiting prostaglandin production via COX-1 and COX-2 enzymes.
  • It has a long half-life (12–17 hours), allowing convenient twice-daily dosing compared to shorter-acting NSAIDs like ibuprofen.
  • The OTC dose for adults is typically 200–250 mg every 8–12 hours, with a maximum of 500 mg per day for self-medication.
  • Common side effects include stomach pain, heartburn, nausea, and headache; serious but rare risks include gastrointestinal bleeding and cardiovascular events.
  • Naproxen must not be used in the last trimester of pregnancy and should be avoided with other NSAIDs, anticoagulants, or in patients with active peptic ulcers.

What Is Naproxen and What Is It Used For?

Quick Answer: Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, inflammation, and fever. It is used for headache, toothache, menstrual cramps, muscle and joint pain, back pain, and acute migraine in adults.

Naproxen belongs to the propionic acid class of NSAIDs, a group of medications that work by inhibiting cyclooxygenase (COX) enzymes. These enzymes—specifically COX-1 and COX-2—are responsible for the production of prostaglandins, lipid compounds that play a central role in mediating pain, inflammation, and fever throughout the body. By reducing prostaglandin synthesis, naproxen effectively addresses all three of these physiological responses simultaneously.

First developed in the 1970s by Syntex Corporation and approved by the U.S. Food and Drug Administration (FDA) in 1976, naproxen has become one of the most widely used pain relievers worldwide. It is available over the counter (OTC) in lower doses in many countries for short-term relief of mild to moderate pain, and by prescription at higher doses for chronic inflammatory conditions. The World Health Organization (WHO) includes naproxen on its Model List of Essential Medicines, recognizing its importance in global healthcare.

Approved Indications

Naproxen is indicated for a broad range of pain and inflammatory conditions. For adults and adolescents aged 12 years and older (weighing over 50 kg), naproxen is approved for the relief of temporary, mild to moderate pain conditions including:

  • Headache – including tension-type headache and mild migraine
  • Toothache – dental pain from various causes
  • Muscle and joint pain – sprains, strains, and overuse injuries
  • Back pain – acute musculoskeletal back pain
  • Menstrual cramps (dysmenorrhea) – primary and secondary
  • Acute migraine attacks – in adults aged 18 years and older

At prescription-strength doses, naproxen is also widely used for the management of chronic inflammatory and rheumatic conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, juvenile arthritis, and gout. In these settings, the full anti-inflammatory benefit may take up to two weeks of regular use to develop, and treatment is typically supervised by a physician.

How Naproxen Works

Naproxen exerts its pharmacological effects through non-selective inhibition of both COX-1 and COX-2 enzymes. COX-2 is primarily induced at sites of tissue damage and inflammation, and its inhibition is largely responsible for the therapeutic anti-inflammatory and analgesic effects. COX-1, on the other hand, is constitutively expressed in the gastrointestinal mucosa, kidneys, and platelets, where it plays protective physiological roles. The inhibition of COX-1 explains many of the adverse effects associated with NSAIDs, particularly gastrointestinal irritation and impaired platelet function.

One of naproxen's distinguishing pharmacokinetic properties is its long elimination half-life of approximately 12 to 17 hours in healthy adults. This is considerably longer than ibuprofen (2–4 hours) or diclofenac (1–2 hours), which means naproxen provides sustained pain relief and typically only needs to be taken twice a day. The drug is well absorbed after oral administration, reaching peak plasma concentrations within 1 to 4 hours depending on the formulation. It is extensively bound to plasma proteins (approximately 99%) and is metabolized primarily in the liver before being excreted by the kidneys.

What Should You Know Before Taking Naproxen?

Quick Answer: Do not take naproxen if you are allergic to NSAIDs, have active stomach or duodenal ulcers, severe liver or kidney disease, severe heart failure, or are in the last three months of pregnancy. Always use the lowest effective dose for the shortest time possible.

Contraindications

Naproxen is contraindicated in several clinical scenarios, and it is essential to be aware of these before starting treatment. You must not take naproxen if any of the following apply:

  • Allergy to naproxen or other NSAIDs – If you have previously experienced allergic reactions such as asthma, rhinitis (runny nose), urticaria (hives), or angioedema after taking aspirin (acetylsalicylic acid) or any other NSAID, you must not take naproxen. Cross-reactivity between different NSAIDs is well documented.
  • Active peptic ulcer disease – If you have or have had recurrent stomach ulcers or duodenal ulcers, or if you have developed ulcers during previous NSAID treatment, naproxen is contraindicated.
  • Increased bleeding tendency – Naproxen inhibits platelet aggregation and prolongs bleeding time, making it unsuitable for patients with coagulation disorders.
  • Severe liver disease – Advanced hepatic impairment significantly alters drug metabolism and increases the risk of adverse effects.
  • Severe kidney disease – NSAIDs reduce renal blood flow by inhibiting prostaglandin-mediated vasodilation in the kidneys, which can worsen existing renal impairment.
  • Severe heart failure – NSAIDs cause sodium and fluid retention, which can exacerbate cardiac failure.
  • Third trimester of pregnancy – Naproxen is absolutely contraindicated during the last three months of pregnancy due to risks to the fetus and complications during delivery (see Pregnancy and Breastfeeding section below).

Warnings and Precautions

Even when naproxen is not strictly contraindicated, there are many situations in which extra caution is warranted. Always speak to your doctor before using naproxen if you have any of the following conditions or risk factors:

  • Inflammatory bowel disease – Conditions such as ulcerative colitis and Crohn's disease may be worsened by NSAID use.
  • Systemic lupus erythematosus (SLE) – NSAIDs can occasionally cause aseptic meningitis in patients with SLE.
  • Asthma – Approximately 10–20% of asthma patients have NSAID-exacerbated respiratory disease. If you have asthma, particularly if accompanied by nasal polyps, use naproxen with extreme caution.
  • Impaired kidney or liver function – Even mild to moderate impairment requires careful dose adjustment and monitoring.
  • Heart failure or hypertension – NSAIDs may cause fluid retention and worsen blood pressure control.
  • History of gastrointestinal problems – Previous GI bleeding, ulceration, or dyspepsia increases the risk of recurrence.
  • Elderly patients – Older adults are at increased risk for all NSAID-related adverse effects, particularly gastrointestinal bleeding and renal impairment. The European Medicines Agency (EMA) and the American Geriatrics Society recommend using NSAIDs with caution in patients over 65 years.

Children and Adolescents

Naproxen should not be used in children under 12 years of age without medical supervision. In adolescents aged 12 and over who weigh more than 50 kg, OTC naproxen may be used for temporary mild to moderate pain. However, for migraine treatment, naproxen is only approved for adults aged 18 years and older. If you suspect your adolescent has migraine, consult a doctor for appropriate evaluation and management rather than self-medicating with naproxen.

Pregnancy and Breastfeeding

The safety of naproxen during pregnancy depends critically on the stage of pregnancy, and this information is vital for women of childbearing age:

First and second trimester (weeks 1–26): Naproxen should only be used during this period if clearly necessary and as advised by your doctor. If treatment is required, the lowest possible dose for the shortest possible time should be used. Importantly, from the 20th week of pregnancy onward, naproxen use for more than a few days can cause kidney problems in the fetus, potentially leading to reduced amniotic fluid (oligohydramnios) or premature closure of the ductus arteriosus in the fetal heart. If prolonged treatment is necessary during this period, your doctor may recommend additional monitoring.

Third trimester (weeks 27–40): Naproxen is absolutely contraindicated. It can cause serious harm to the unborn baby, including kidney and heart problems. It can also affect the mother's and baby's tendency to bleed and may delay or prolong labor. These risks are well documented for all NSAIDs and are reflected in regulatory guidance from the FDA, EMA, and WHO.

Breastfeeding: Naproxen passes into breast milk in small quantities. While it is unlikely to affect a breastfed infant at therapeutic doses, it is advisable to consult your doctor before using naproxen while breastfeeding, especially for prolonged periods. The American Academy of Pediatrics considers naproxen compatible with breastfeeding, but caution is still recommended.

Fertility: Naproxen may temporarily impair female fertility by inhibiting ovulation. If you are trying to conceive or experiencing difficulty becoming pregnant, discuss this with your doctor. This effect is reversible upon discontinuation of the drug.

Driving and Operating Machinery

Naproxen can cause side effects such as dizziness, drowsiness, and visual disturbances that may impair your ability to drive or operate machinery safely. You should be aware of how the medication affects you before engaging in activities requiring alertness, such as driving or performing precision work. If you experience any of these effects, avoid such activities until you feel fully capable.

How Does Naproxen Interact with Other Drugs?

Quick Answer: Naproxen interacts with many medications including blood thinners (warfarin, aspirin), lithium, methotrexate, ACE inhibitors, diuretics, SSRIs, and other NSAIDs. Do not combine different pain relievers without medical advice.

Drug interactions are an important safety consideration when taking naproxen. Because NSAIDs affect prostaglandin synthesis, platelet function, and renal blood flow, they can interact with a wide range of other medications, potentially increasing the risk of adverse effects or reducing the efficacy of either drug. Always inform your doctor or pharmacist about all medications you are taking, including over-the-counter drugs and herbal supplements.

Major Interactions

The following interactions are considered clinically significant and may require dose adjustments, additional monitoring, or avoidance of concomitant use:

Major Drug Interactions with Naproxen
Drug / Drug Class Interaction Clinical Significance
Warfarin & anticoagulants Increased risk of bleeding due to additive antiplatelet and anticoagulant effects High – monitor INR closely, avoid if possible
Aspirin (low-dose) Naproxen may interfere with the cardioprotective antiplatelet effect of low-dose aspirin; increased GI bleeding risk High – take aspirin at least 2 hours before naproxen if combination is necessary
Lithium NSAIDs reduce renal lithium clearance, leading to elevated and potentially toxic lithium levels High – monitor lithium levels frequently
Methotrexate Reduced renal clearance of methotrexate, increasing toxicity risk (myelosuppression, hepatotoxicity) High – avoid during high-dose methotrexate therapy
Other NSAIDs No additional therapeutic benefit; significantly increased risk of GI ulceration and bleeding High – never combine two NSAIDs
Cyclosporine / Tacrolimus Additive nephrotoxicity; increased risk of renal impairment High – monitor renal function closely

Moderate Interactions

These interactions are clinically relevant but may not always require avoidance. Monitoring and possible dose adjustments are typically recommended:

Moderate Drug Interactions with Naproxen
Drug / Drug Class Interaction Clinical Significance
ACE inhibitors & ARBs NSAIDs reduce the antihypertensive effect; combined use increases risk of renal impairment and hyperkalemia Moderate – monitor blood pressure and renal function
Diuretics NSAIDs reduce the natriuretic effect of diuretics; increased risk of acute kidney injury with triple therapy (NSAID + ACE inhibitor/ARB + diuretic) Moderate – ensure adequate hydration, monitor renal function
Beta-blockers Reduced antihypertensive effect due to prostaglandin inhibition Moderate – monitor blood pressure
SSRIs (antidepressants) Increased risk of gastrointestinal bleeding due to additive effects on platelet function Moderate – consider gastroprotection
Corticosteroids Increased risk of GI ulceration and bleeding Moderate – consider gastroprotection
Probenecid Probenecid reduces renal clearance of naproxen, increasing plasma levels and half-life Moderate – dose adjustment may be needed

Food and Alcohol Interactions

Naproxen can be taken with or without food. Taking it with food does not reduce its effectiveness but may slightly delay the onset of action. Taking naproxen with food or milk can help reduce stomach irritation, which is a practical recommendation for patients who experience gastrointestinal discomfort.

Alcohol should be used with caution while taking naproxen. Both alcohol and NSAIDs irritate the gastric mucosa independently, and their combination significantly increases the risk of gastrointestinal bleeding. The FDA recommends that people who drink three or more alcoholic beverages daily should consult their doctor before using any NSAID, including naproxen.

What Is the Correct Dosage of Naproxen?

Quick Answer: For OTC use, adults and adolescents (12+ years, over 50 kg) take 200–250 mg as needed, up to 500 mg per day. For acute migraine in adults (18+), take 500–750 mg at onset, then 250 mg as needed, up to 1250 mg on the first day. Always use the lowest effective dose.

Correct dosing of naproxen is essential for achieving effective pain relief while minimizing the risk of adverse effects. The dose varies depending on the indication, the patient's age and weight, and whether the medication is used as OTC self-medication or as a prescription treatment. Always follow the instructions on the packaging or your doctor's specific directions.

Adults (18 years and older)

For Mild to Moderate Pain (OTC)

Dose: 200–250 mg as needed
Maximum daily dose: 500 mg per 24 hours
Duration: Do not exceed 5 days for pain without medical advice
Note: The tablet may be split in half for flexible dosing (250 mg tablets)

For Acute Migraine (Adults Only)

Initial dose: 500–750 mg at the first sign of migraine
Subsequent doses: 250 mg as needed
Maximum daily dose: 1250 mg on the first day
Duration: Consult a doctor if migraine is not relieved within 3 days
Note: It is essential to take naproxen at the very first sign of a migraine for best results

Prescription Doses (Under Medical Supervision)

Typical dose: 250–500 mg twice daily
Maximum daily dose: 1000–1250 mg (varies by indication)
For inflammatory conditions: Regular dosing for up to 2 weeks may be needed for full anti-inflammatory effect
Note: Higher doses require medical supervision and regular monitoring

Adolescents (12–17 years, over 50 kg)

For Mild to Moderate Pain (OTC)

Dose: 250 mg as needed
Maximum daily dose: 500 mg per 24 hours
Duration: Do not exceed 5 days for pain without medical advice
Note: Not recommended for adolescents under 50 kg without medical advice. Not approved for migraine treatment in adolescents—consult a doctor instead.

Elderly Patients

Older adults are at significantly increased risk for NSAID-related adverse effects, particularly gastrointestinal bleeding, renal impairment, and cardiovascular events. The following principles apply:

  • Use the lowest effective dose for the shortest possible time
  • Monitoring of renal function, blood pressure, and gastrointestinal symptoms is recommended
  • Consider co-prescribing a proton pump inhibitor (PPI) for gastrointestinal protection
  • Be alert to the signs and symptoms of GI bleeding, which may present without warning
  • Regularly reassess the need for continued NSAID therapy

Missed Dose

If you forget to take a dose of naproxen, take it as soon as you remember unless it is nearly time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a forgotten dose. When used as-needed for pain relief, a missed dose is generally not a concern—simply take the next dose when pain returns.

Overdose

What Are the Side Effects of Naproxen?

Quick Answer: Common side effects include stomach pain, heartburn, nausea, diarrhea, headache, and dizziness. Uncommon effects include asthma, skin reactions, and gastrointestinal bleeding. Rare but serious effects include Stevens-Johnson syndrome, liver damage, and cardiovascular events.

Like all medications, naproxen can cause side effects, although not everyone experiences them. The risk of side effects generally increases with higher doses and longer treatment duration, which is why the fundamental principle of NSAID use—lowest effective dose for the shortest possible time—is so important. Most common side effects are mild and resolve when the medication is discontinued.

Common

May affect up to 1 in 10 people

  • Stomach pain, heartburn, nausea
  • Diarrhea, constipation
  • Mouth inflammation
  • Skin rash, superficial skin ulcers
  • Drowsiness, headache, dizziness
  • Thirst, sweating
  • Tinnitus (ringing in the ears)
  • Visual disturbances
  • Fluid retention (edema)
  • Palpitations

Uncommon

May affect up to 1 in 100 people

  • Shortness of breath, asthma exacerbation
  • Hives, photosensitivity (skin changes from sun exposure)
  • Gastrointestinal bleeding, stomach ulcers
  • Inflammation and ulcers in the mouth and esophagus
  • Gastritis (stomach lining inflammation)
  • Fever, hair loss
  • Liver function impairment
  • Kidney function impairment
  • Hearing impairment
  • Insomnia, difficulty concentrating

Rare

May affect up to 1 in 1,000 people

  • Seizures, muscle weakness
  • Blood count changes (anemia, thrombocytopenia, leukopenia)
  • Perforated peptic ulcer, colitis, pancreatitis
  • Blood in stool, vomiting blood
  • Erythema multiforme (red skin patches on hands and feet)
  • Pneumonitis (lung inflammation)
  • Hepatitis (liver inflammation)
  • Blood in urine (hematuria)
  • Depression, nightmares, cognitive impairment
  • Aseptic meningitis
  • Vasculitis, heart failure, elevated blood pressure
  • Hyperkalemia (elevated potassium levels)
  • Worsening of Crohn's disease or ulcerative colitis

Cardiovascular Risk

All NSAIDs carry a warning about potential cardiovascular risks. Medicines like naproxen may be associated with a small increased risk of heart attack or stroke, particularly when used at high doses and for long periods. However, it is worth noting that the 2013 meta-analysis by the Coxib and traditional NSAID Trialists' (CNT) Collaboration, published in The Lancet and analyzing over 600 randomized trials, found that naproxen was not associated with a significant increase in major vascular events, unlike some other NSAIDs. This has led regulatory agencies including the EMA to characterize naproxen as having a comparatively favorable cardiovascular profile among non-selective NSAIDs, though it is not entirely free of risk.

Gastrointestinal Risk

The gastrointestinal tract is the organ system most commonly affected by NSAID use. Naproxen, like all non-selective NSAIDs, inhibits COX-1 in the gastric mucosa, reducing the production of protective prostaglandins that maintain the mucosal barrier. This can lead to a spectrum of effects ranging from mild dyspepsia to serious complications such as peptic ulcers, gastrointestinal perforation, and hemorrhage. Risk factors for serious GI events include advanced age, history of peptic ulcer disease, concomitant use of anticoagulants or corticosteroids, and high-dose or prolonged NSAID use. For patients at increased GI risk who require NSAID therapy, co-prescribing a proton pump inhibitor (PPI) is strongly recommended by clinical guidelines including those from NICE and the American College of Gastroenterology.

Reporting Side Effects

If you experience any side effects while taking naproxen, including those not listed here, report them to your healthcare provider. You can also report suspected side effects to your national pharmacovigilance authority (e.g., the FDA MedWatch program in the United States or the Yellow Card Scheme in the United Kingdom). Reporting side effects helps monitor the ongoing safety of medicines.

How Should You Store Naproxen?

Quick Answer: Store naproxen at room temperature, out of the reach and sight of children. Do not use after the expiration date. Dispose of unused medication properly through a pharmacy take-back program.

Proper storage of naproxen is important for maintaining the medication's effectiveness and safety. Follow these storage guidelines:

  • Keep out of the reach and sight of children – This is the most critical storage requirement. Accidental ingestion by children is a medical emergency.
  • Store at room temperature – Generally below 25°C (77°F), unless otherwise directed on the packaging. Avoid exposure to excessive heat, moisture, and direct sunlight.
  • Check the expiration date – Do not use naproxen after the expiration date printed on the packaging (EXP). The expiration date refers to the last day of the indicated month.
  • Proper disposal – Do not discard unused medications in household waste or flush them down the drain. Return unused naproxen to a pharmacy or use a medication take-back program to protect the environment.

If the tablets appear discolored, crumbled, or damaged, do not use them. Contact your pharmacist for a replacement if your medication shows signs of deterioration before the expiration date.

What Does Naproxen Contain?

Quick Answer: The active ingredient is naproxen (available in 200 mg, 250 mg, and 500 mg strengths). Common inactive ingredients include lactose monohydrate, corn starch, gelatin, talc, magnesium stearate, and sodium starch glycolate. Formulations may vary between brands.

Understanding the composition of naproxen tablets can be important, particularly if you have allergies or intolerances to specific excipients. While the active ingredient is the same across all brands, the inactive ingredients (excipients) may vary between manufacturers.

Active Ingredient

Each tablet contains naproxen as the active pharmaceutical ingredient. The most commonly available strengths are:

  • 200 mg – soft capsule formulation (OTC)
  • 250 mg – standard tablet formulation (OTC and prescription)
  • 500 mg – tablet and enteric-coated tablet formulation (prescription)

Common Inactive Ingredients (Excipients)

Typical inactive ingredients found in naproxen tablets include:

  • Lactose monohydrate (a milk sugar—inform your doctor if you have lactose intolerance)
  • Corn starch (maize starch)
  • Gelatin
  • Talc
  • Magnesium stearate
  • Sodium starch glycolate
Sodium Content

Standard naproxen tablets contain less than 1 mmol (23 mg) of sodium per tablet, which is essentially sodium-free. This is relevant for patients on a sodium-restricted diet. Note that naproxen sodium formulations (such as those marketed under the brand name Aleve) contain additional sodium as part of the salt form and may have a slightly higher sodium content per dose.

Available Formulations

Naproxen is available in several formulations designed to meet different clinical needs:

  • Standard tablets – white, round, biconvex tablets with a score line for splitting; the most common formulation.
  • Enteric-coated tablets – designed with a special coating that resists stomach acid, releasing naproxen in the small intestine instead. This may reduce direct gastric irritation but does not eliminate the systemic GI risks of NSAIDs.
  • Soft capsules – contain naproxen in a liquid form within a soft gelatin shell, which may allow for faster absorption and onset of action.
  • Modified-release tablets – formulations combining naproxen with other agents (e.g., esomeprazole) for enhanced gastric protection during long-term use.

Frequently Asked Questions About Naproxen

Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve mild to moderate pain, including headache, toothache, menstrual cramps, muscle and joint pain, and back pain. In adults aged 18 and over, it can also be used for acute migraine attacks. At prescription doses, it is used for chronic inflammatory conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and gout. It works by reducing prostaglandins that cause pain, inflammation, and fever.

Naproxen typically begins to relieve pain within 30 to 60 minutes after taking it orally on an empty stomach. If taken with food, the onset may be slightly delayed but the overall effectiveness is not reduced. Peak plasma concentrations are usually reached within 1 to 4 hours depending on the formulation. For chronic inflammatory conditions, the full anti-inflammatory effect may take up to two weeks of regular dosing to develop.

No, you should not take naproxen and ibuprofen together. Both are NSAIDs that work through the same mechanism (COX inhibition), so combining them provides no additional benefit but significantly increases the risk of serious side effects including gastrointestinal bleeding, ulcers, and kidney damage. If one NSAID is not providing adequate relief, consult your doctor about alternative options such as adding acetaminophen (paracetamol) or switching to a different pain management approach rather than combining two NSAIDs.

Naproxen should not be used during the last three months of pregnancy (third trimester) as it can harm the unborn baby and cause complications during delivery, including kidney and heart problems in the fetus, bleeding tendency, and delayed labor. During the first six months, it should only be used if clearly necessary and as advised by a doctor, using the lowest effective dose for the shortest time. From week 20 onwards, prolonged use can cause kidney problems in the fetus, potentially leading to reduced amniotic fluid. If you are pregnant or planning to become pregnant, always consult your doctor before taking any NSAID.

The most common side effects of naproxen (affecting up to 1 in 10 people) include stomach pain, heartburn, nausea, diarrhea, constipation, mouth inflammation, skin rash, drowsiness, headache, dizziness, thirst, sweating, tinnitus, visual disturbances, fluid retention, and palpitations. Most of these are mild and resolve when the medication is stopped. To reduce the risk of gastrointestinal side effects, take naproxen with food and use the lowest effective dose for the shortest possible time.

Naproxen and ibuprofen are both NSAIDs but differ mainly in their duration of action and dosing frequency. Naproxen has a longer half-life (12–17 hours) compared to ibuprofen (2–4 hours), so naproxen is typically taken twice daily while ibuprofen is taken three to four times daily. Studies, including the large CNT Collaboration meta-analysis in The Lancet, suggest that naproxen may carry a slightly lower cardiovascular risk than some other NSAIDs, though both share similar gastrointestinal risks. The choice between them depends on individual patient factors including convenience, cardiovascular risk profile, and response to treatment.

References

All information in this article is based on current international medical guidelines, regulatory documents, and peer-reviewed research. No commercial funding was involved in the creation of this content.

  1. Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. The Lancet. 2013;382(9894):769–779. doi:10.1016/S0140-6736(13)60900-9
  2. European Medicines Agency (EMA). Naproxen – Summary of Product Characteristics. Available at: www.ema.europa.eu
  3. U.S. Food and Drug Administration (FDA). Naproxen Sodium Label. Available at: www.fda.gov
  4. World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. 2023. Available at: www.who.int
  5. National Institute for Health and Care Excellence (NICE). NSAIDs – prescribing issues. Clinical Knowledge Summary. 2024. Available at: cks.nice.org.uk
  6. British National Formulary (BNF). Naproxen Monograph. Available at: bnf.nice.org.uk
  7. Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol. 2008;52(18):1502–1517.
  8. Lanas A, Chan FKL. Peptic ulcer disease. The Lancet. 2017;390(10094):613–624.
  9. Todd PA, Clissold SP. Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs. 1990;40(1):91–137.
  10. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098.

Medical Editorial Team

This article was written and reviewed by the iMedic Medical Editorial Team, which consists of licensed physicians, pharmacists, and medical researchers with expertise in clinical pharmacology and pain management. All content follows the GRADE evidence framework and adheres to international medical guidelines from WHO, EMA, FDA, and NICE.

Evidence-Based Content

All medical claims in this article are supported by Level 1A evidence from systematic reviews, meta-analyses of randomized controlled trials, and current international clinical guidelines. Sources include the CNT Collaboration meta-analysis, EMA product information, FDA labeling, WHO Essential Medicines List, and NICE clinical knowledge summaries.

Editorial Independence

iMedic receives no commercial funding from pharmaceutical companies. Our editorial content is entirely independent, with no advertising, sponsorship, or conflicts of interest. All content is reviewed according to our rigorous editorial standards.